Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179946 · ClinicalTrials.gov registry record
HLA Matching - Unrelated Umbilical Cord Blood Transplantation
A clinical trial of Hematologic Diseases, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00179946 is a study of Hematologic Diseases that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 30 participants, below the 2,236-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00179946, a study of Hematologic Diseases, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
Conditions Studied
Interventions
- PROCEDURE HLA typing
Study Locations (1)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179946
The ClinicalTrials.gov registry entry for NCT00179946 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,236-participant average among 17 other Hematologic Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hematologic Diseases appearing as the primary indexed condition, and to 1 intervention - of which HLA typing is the first listed.
NCT00179946 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00179946 about?
NCT00179946 is a clinical study titled "HLA Matching - Unrelated Umbilical Cord Blood Transplantation". The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
What is the current status of trial NCT00179946?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2003-06. Estimated completion is 2006-04.
What conditions does trial NCT00179946 study?
This clinical trial studies the following conditions: Hematologic Diseases.
What interventions are being tested in trial NCT00179946?
The interventions under investigation include: HLA typing (PROCEDURE).
Who is sponsoring clinical trial NCT00179946?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179946 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
RECRUITING · Phase 1
-
The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research
RECRUITING
-
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RECRUITING · Phase 1
-
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.